FDA recall D-0006-2017
Shire · Class III · drug
Product
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Reason for recall
Presence of Foreign Tablets/Capsules
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2016-09-02
- Report date
- 2016-10-12
- Termination date
- 2019-03-08
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Chesterbrook, PA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0006-2017